|
Combined Treatments with a Retinoid Receptor Agonist and Epigenetic Modulators in Human Neuroblastoma Cells
|
22 November 2016 |
|
Vitamin D in haematological disorders and malignancies
|
18 November 2016 |
|
Effect of β-carotene on cancer cell stemness and differentiation in SK-N-BE(2)C neuroblastoma cells
|
18 November 2016 |
|
Decreased preoperative serum 25-Hydroxyvitamin D levels in colorectal cancer are associated with systemic inflammation and serrated morphology
|
15 November 2016 |
|
Melatonin, sleep, and prostate cancer in elderly men: study, hypothesis development, and icelandic options
|
15 November 2016 |
|
Predictive factors of antiproliferative activity of octreotide LAR as first-line therapy for advanced neuroendocrine tumours
|
11 November 2016 |
|
Urinary excretion of melatonin and association with breast cancer: meta-analysis and review of the literature
|
11 November 2016 |
|
Urinary melatonin levels, sleep disruption, and risk of prostate cancer in elderly men
|
11 November 2016 |
|
Alterations in Retinoic Acid Receptors in Non-Small Cell Lung Cancer and Their Clinical Implications
|
04 November 2016 |
|
Disruption of Vitamin D and Calcium Signaling in Keratinocytes Predisposes to Skin Cancer
|
04 November 2016 |